Biobanks Explained: The Infrastructure Behind Better Healthcare

In 2022, over 80% of genomic studies worldwide were based on data from Western populations. India — home to one-sixth of humanity — contributed less than 2%. This gap has real consequences: treatments, diagnostics, and drug responses developed elsewhere often don’t account for Indian genetic and environmental diversity.

This is where biobanks can change the story.

Biobanks are long-horizon research engines that determine whether a country participates in the future of precision healthcare or gets left behind. As India invests in next-generation health science, understanding what biobanks do — and why they matter — becomes essential.

What Is a Biobank? Understanding Medical Research’s Essential Infrastructure

A Biobank is a specialized facility that collects, processes, stores, and manages human biospecimens along with their associated clinical information. These biospecimens such as blood, serum, plasma, tissue samples, DNA, RNA, and microbial isolates along with associated health data for medical research.

Unlike hospital laboratories that analyze samples for immediate diagnosis, biobanks preserve  specimens for long-term research that can span decades. These collections become invaluable resources for scientists developing personalized treatments, understanding disease patterns, and creating diagnostic tools tailored to diverse populations.

What do Biobanks store?

Modern biobanks maintain diverse collections of human biospecimens including blood samples (serum and plasma), DNA and RNA for genetic analysis, tissue samples from biopsies, cell lines for laboratory research, and microbial isolates for infectious disease studies. 

The Sri Sathya Sai Biobank and Research Hub (SSSBRH), affiliated with SSSIHL, exemplifies this comprehensive approach. With over 25,000 existing samples including 10,000 antimicrobial resistance bacterial isolates, 5,000 cardiovascular disease specimens, and 5,000 infectious disease samples, it demonstrates how biobanks create research-ready collections addressing India’s specific health challenges.

How Biobanks Work

Biobanking follows a rigorous three-stage process. First, clinical samples are collected from consenting individuals through established ethical protocols at healthcare facilities. These samples undergo standardized processing in advanced laboratories like SSSBRH’s BSL-1 and BSL-2 facilities within their 50,000 sq ft Central Research Instruments Facility.

Next comes preservation using sophisticated cryogenic systems that maintain samples at ultra-low temperatures (-80°C, -150°C, and -180°C) with full redundancy to ensure long-term viability. SSSBRH employs on-site liquid nitrogen generation producing 20 liters daily, which will be expanded to 30 liters daily in coming years , ensuring continuous operations without external dependencies.

Finally, biobanks distribute samples to qualified researchers globally, accelerating medical discoveries that would be impossible for individual institutions to conduct alone. This collaborative model transforms isolated healthcare data into powerful research tools.

India’s long-standing absence in global health datasets is not a statistic we must accept. 

As India’s population remains dramatically underrepresented in global precision medicine datasets, facilities like the Sri Sathya Sai Biobank and Research Hub don’t just preserve biological samples, they preserve the possibility that future treatments will work equally well for Indian patients as they do for populations historically studied in Western research.

In that sense, a biobank is a long-term commitment to scientific equity. And for a country as diverse as ours, it may become one of the most important assets shaping the next generation of healthcare.

Other prominent biobanks:
National Cancer Tissue Biobank (IIT Madras), National Liver Disease Biobank (ILBS Delhi), National Centre for Cell Science Biobank (Pune), CSIR-Institute of Microbial Technology Biobank (Chandigarh), NIMHANS Brain Bank (Bengaluru), JALMA Biobank (Agra), TiMBR Biorepository (Tata Medical Centre Kolkata), Sapien BioSciences Biobank (Hyderabad), THSTI Biorepository (Faridabad), ADBAS Biobank (Bengaluru)

Why Academic Biobanks Accelerate Research That India Actually Needs

India’s genetic diversity is one of the richest in the world. Populations vary across regions, ethnicities, and socio-cultural groups. Yet this diversity remains under-represented in global datasets, limiting the development of targeted diagnostics and personalized therapeutics.​

Majority of global biobank biospecimens are of European ancestry, severely underrepresenting Indians. Since genetic variations affecting disease risk, drug response, and metabolism differ across populations, diagnostics and medicines developed mainly from European data often work sub-optimally, or even unsafely, for Indian patients.​

So how do we bridge this genetic diversity gap? 

And perhaps more importantly—why hasn’t it been filled already?​

The challenge lies not in awareness, but in infrastructure and integration. Building a biobank requires more than freezers and laboratories—it demands a rare convergence of clinical access, research capability, ethical frameworks, and long-term institutional commitment. Most research institutions lack direct healthcare networks, while hospitals often lack research infrastructure. This structural disconnect has kept India’s genetic diversity largely unmapped, despite housing 17% of the world’s population.​​

Biobanks can fill this gap by systematically collecting and curating bio-specimen from across the population. Such datasets enable:

• More accurate disease risk prediction
• Region-specific biomarker discovery
• Better understanding of lifestyle–gene interactions
• Improved precision medicine for Indian communities

SSSBRH: The unique advantage of an integrated ecosystem approach.

The Sri Sathya Sai Biobank and Research Hub (SSSBRH) goes a step further by embedding biobanking within a full research-to-clinic ecosystem.. Unlike traditional biobanks that operate in isolation, SSSBRH brings together three critical pillars under one unified vision:​​

• Academicians from Sri Sathya Sai Institute of Higher Learning (SSSIHL) training the next generation of biomedical scientists with hands-on research experience.​​
• Innovators and researchers conducting cutting-edge translational studies in state-of-the-art BSL-1 and BSL-2 facilities spanning 50,000 sq ft.​
• Healthcare infrastructure through SSSIHMS tertiary hospitals, Sri Sathya Sai General Hospitals, and mobile hospital units that reach remote villages—providing continuous access to diverse patient populations across urban, semi-urban, and rural settings.​

Institutional alignment through the Sri Sathya Sai Central Trust, ensuring that education, research, and healthcare all advance toward a shared mission: making precision medicine accessible and effective for every Indian.​

This integrated model creates a self-sustaining cycle where education drives research excellence, research enhances healthcare delivery, and healthcare informs future educational priorities. The SSSBRH demonstrates how India can leapfrog traditional biobanking limitations by building complete ecosystems rather than isolated facilities.​Academic biobanks like the Sri Sathya Sai Biobank and Research Hub (SSSBRH) in association with SSSIHL possess unique advantages. They integrate three essential pillars: 

• Education for training the next generation of biomedical scientists,
• Research enabling cutting-edge translational studies, and 
• Healthcare providing continuous access to diverse patient populations.

“This integrated ecosystem creates a self-sustaining cycle where education drives research excellence, research enhances healthcare delivery, and healthcare informs future educational priorities.” 

The SSSBRH demonstrates how academic biobanks catalyze translational medicine. Building upon a decade of research, it houses 25,000+ samples including 10,000 antimicrobial resistance bacterial isolates, 5,000 cardiovascular disease specimens, 5,000 infectious disease samples, and 5,000 neuropsychiatric research biospecimens.

Academic biobanks can strategically focus on conditions causing maximum health and economic impact. For communicable diseases, India’s high antimicrobial resistance burden requires dedicated bacterial pathogen collections for surveillance and therapeutic development. 

India stands at a crossroads. The country can either develop robust academic biobanking infrastructure to support its precision medicine ambitions, or continue relying on inadequate capacity and external data that doesn’t reflect Indian diversity. 

Academic biobanks like SSSBRH demonstrate what’s possible when institutions combine education, research, and healthcare under principles of service to humanity.